Unfortunately after the FDA meeting I expect msb will get a crl...

Unfortunately after the FDA meeting I expect msb will get a crl (complete responce letter) this will ask for more confirmatory data which of course msb will struggle to provide they will not know how to create anymore compelling data than they have provided. The stratagy of cloaking their drug as a possible covid treatment has not fooled the FDA or convinced them to provide an easy path. As msb's eggs are all in one basket the sp will head back down to cents big holders are sneaking out now when the CRL drops there will be a rush to the door to exit this one trick pony. All in my opinion of course so DYOR